Back to Search Start Over

Nanoparticles crossing blood–brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions.

Authors :
Ljubimova, Julia Y
Holler, Eggehard
Black, Keith L
Ljubimov, Alexander V
Source :
Nanomedicine; 2024, Vol. 19 Issue 23, p1863-1866, 4p
Publication Year :
2024

Details

Language :
English
ISSN :
17435889
Volume :
19
Issue :
23
Database :
Complementary Index
Journal :
Nanomedicine
Publication Type :
Academic Journal
Accession number :
180108943
Full Text :
https://doi.org/10.1080/17435889.2024.2380241